StockWatch
·

Fortress Biotech, Inc. Q3 FY25 Results

FBIOQ3 FY25 Results
Filing
MetricValue ($ M)Q2 FY25Q3 FY24
Revenue17.637.4%20.5%
Total Income17.637.4%20.5%
Expenditure24.4453.8%33.4%
PBT8.85133.2%
Net Profit5.8562.2%145.4%
OPM-38.63%
NPM33.18%61.17pp121.14pp
EPS0.1374.0%117.1%
View full financials

Fortress Biotech Reports Q3 2025 Results

04 May 2026 · 4 May, 7:09 am

Summary

Fortress Biotech, Inc. issued a press release on November 14, 2025, to announce its financial results for the quarter ended September 30, 2025. The press release also provided a corporate update. The press release is furnished as Exhibit 99.1 to the report. The information contained within the Form 8-K, including the exhibit, is furnished and not filed for the purposes of Section 18 of the Securities Exchange Act of 1934.

Key Highlights

  1. 1

    Fortress Biotech, Inc. announced its financial results for the quarter ended September 30, 2025.

  2. 2

    A press release was issued to provide a corporate update and announce the financial results.

  3. 3

    The press release is dated November 14, 2025.

  4. 4

    The information is furnished as Exhibit 99.1 to the report.

Informational and educational content only. Not investment advice.